Dry Eye Syndrome Market: Global Industry Trends, Growth, Size, and Forecast 2035
The Dry Eye Syndrome Market is expanding as growing screen exposure, aging populations, environmental conditions, and increasing awareness of ocular health contribute to rising demand for effective treatment options. According to Market Research Future, the market was valued at USD 6.80 billion in 2025 and is projected to reach USD 10.30 billion by 2035, registering a CAGR of 4.25% during 2026–2035.
The market includes artificial tears, anti-inflammatory drugs, punctal plugs, surgical devices, diagnostic solutions, and other treatment approaches. Eye drops remain the leading dosage form because of their familiarity and ease of administration. Prescription therapies are also gaining importance as patients and clinicians increasingly focus on long-term disease management rather than temporary symptom relief.
Rising digital screen exposure is an important market driver because prolonged screen use can contribute to reduced blinking and tear-film instability. Aging demographics further support demand, particularly in developed healthcare markets.
North America held approximately 38% of global market revenue in 2025, supported by advanced healthcare infrastructure and high diagnosis rates. Asia-Pacific is expected to register the fastest growth through 2035, driven by tele-ophthalmology, improving healthcare access, and rising awareness.
Overall, technological innovation, preservative-free formulations, advanced diagnostics, and emerging therapies are expected to create significant opportunities for companies operating in the Dry Eye Syndrome Market.